Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DoctorAdam vs Tablet Health

DoctorAdam
Graded #54

Higher grade

vs+28.300000000000004
Tablet Health
Graded #495

Lower grade

The verdict

DoctorAdam takes it — 75.9/100 to 47.6/100.

DoctorAdam grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DoctorAdam is a Shopify-based telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral tablet forms, with flat all-in monthly pricing covering physician evaluation,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDoctorAdam +33
78
45
Dose & formulationDoctorAdam +37
88
51
Clinical oversightDoctorAdam +48
85
37
Labs & monitoringDoctorAdam +3
53
50
FulfillmentDoctorAdam +22
79
57
Contract termsEven
55
55
DoctorAdam · left barTablet Health · right bar

The numbers

MetricDoctorAdamTablet Health
WeighScore75.9/10047.6/100
GradeCC
Scorecard rank#54#495
Semaglutide$129/mo (starting dose, compounded)Not disclosed
Tirzepatide$229/mo (starting dose, compounded)Not disclosed
Coverage44 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
DoctorAdam

Graded #54 · C

Strengths

  • Offers both injection and oral tablet forms of compounded semaglutide and tirzepatide
  • Flat all-in pricing — physician evaluation, medication, and free shipping included
  • Named pharmacy partners: Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX)
  • LegitScript certified with 4.8/5 Trustpilot score from 5,400+ reviews and 100K+ patients
  • No hidden fees, no required recurring commitment, full refund if not prescribed

Where it loses points

  • Compounded medications are not FDA-approved individual drugs
  • No labs or dedicated coaching disclosed on public pages
  • Only 44 states served — AK, MA, MS, NJ, RI, and VT excluded despite homepage '50 states' claim
  • Dose-tier pricing not published; only starting prices visible without quiz
  • Shopify-based store rather than a dedicated health platform
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard